Denise Pollard-Knight

Bio

Has been responsible for the Team's life science investment activities since joining in 1999 and has over ten years experience as a venture capitalist, having previously been an investment manager in the Bioscience Unit of Rothschild Asset Management, a group managing over $500 million in private and public biotechnology companies. Has held senior management positions in R&D and in strategic consulting. At Phase4 Ventures, responsible for leading the Team and investment strategy. Actively involved in US and European investments, especially spin-outs. Director of Nomura Phase4 Ventures Ltd and a member of the Investment Committee. Director of Nabriva, Cerimon, Idenix and DeveloGen and previously a Director on the board of Viacell and an observer on the board of Ark Therapeutics. Member of the Board of Trustees and Council of the British Heart Foundation and holds a Diploma in Company Direction from the Institute of Directors. PhD and BSc (Hons) from Birmingham University and was a Fulbright Scholar at the University of California, Berkeley.